| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-06405-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90127-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89229-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-99484-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-99718-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34863-10ug | |||
| Carrier-Free | NBP2-34863-1mg | |||
| Carrier-Free | NBP2-34863-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81117-0.025mg | |||
![Immunohistochemistry-Paraffin: Dicer Antibody [NBP3-30965] - Immunohistochemical staining of FFPE human colon carcinoma tissue using Dicer antibody (Cat. No. NBP3-30965). Antibody used at 1 ug/ml and visualized using DAB. Pathologists Comments: Cytoplasmic staining on mucous cells.](http://images.novusbio.com/fullsize/nbp3-30965_rabbit-dicer-pab-811202420592150.jpg "Immunohistochemistry-Paraffin: Dicer Antibody [NBP3-30965] - Immunohistochemical staining of FFPE human colon carcinoma tissue using Dicer antibody (Cat. No. NBP3-30965). Antibody used at 1 ug/ml and visualized using DAB. Pathologists Comments: Cytoplasmic staining on mucous cells.")
![Immunohistochemistry-Paraffin: MYD118 Antibody [NBP3-06405] - Immunochemical staining of MYD118 Antibody in human placenta with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/MYD118-Antibody-Immunohistochemistry-Paraffin-NBP3-06405-img0002.jpg "Immunohistochemistry-Paraffin: MYD118 Antibody [NBP3-06405] - Immunochemical staining of MYD118 Antibody in human placenta with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections.")
![Immunohistochemistry-Paraffin: MYD118 Antibody [NBP3-06405] - Immunochemical staining of MYD118 Antibody human kidney with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/MYD118-Antibody-Immunohistochemistry-Paraffin-NBP3-06405-img0001.jpg)
![Flow Cytometry: FABP6 Antibody (201) [NBP2-90127] - Flow cytometric analysis of Human FABP6 expression on MCF-7 cells. The cells were treated according to manufacturer's manual (BD Pharmingen™ Cat. No. 554714), stained with purified anti-Human FABP6, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/FABP6-Antibody-201-Flow-Cytometry-NBP2-90127-img0002.jpg "<b>Biological Strategies Validation. </b>Flow Cytometry: FABP6 Antibody (201) [NBP2-90127] - Flow cytometric analysis of Human FABP6 expression on MCF-7 cells. The cells were treated according to manufacturer's manual (BD Pharmingen™ Cat. No. 554714), stained with purified anti-Human FABP6, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: FABP6 Antibody (201) [NBP2-90127] - Immunofluorescence staining of Human FABP6 in MCF7 cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-90127 antibody (1:60) at 37? 1 hour. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp2-90127_rabbit-monoclonal-fabp6-antibody-201-2352025162810.png)
![Western Blot: Uev1a/UBE2V1 Antibody [NBP2-88550] - WB Suggested Anti-UBE2V1 Antibody. Titration: 1.0 ug/ml. Positive Control: Fetal Brain](http://images.novusbio.com/fullsize/Uev1a-UBE2V1-Antibody-Western-Blot-NBP2-88550-img0001.jpg "Western Blot: Uev1a/UBE2V1 Antibody [NBP2-88550] - WB Suggested Anti-UBE2V1 Antibody. Titration: 1.0 ug/ml. Positive Control: Fetal Brain")
![Western Blot: Uev1a/UBE2V1 Antibody [NBP2-88550] - Host: Rabbit. Target Name: UBE2V1. Sample Tissue: Human Jurkat Whole Cell. Antibody Dilution: 1ug/ml](http://images.novusbio.com/fullsize/Uev1a-UBE2V1-Antibody-Western-Blot-NBP2-88550-img0002.jpg)
![Immunohistochemistry-Paraffin: IFITM1 Antibody (001) [NBP2-89229] - Staining of human IFITM1 in human colon carcinoma with rabbit monoclonal antibody (1:200.)](http://images.novusbio.com/fullsize/IFITM1-Antibody-001-Immunohistochemistry-Paraffin-NBP2-89229-img0002.jpg "Immunohistochemistry-Paraffin: IFITM1 Antibody (001) [NBP2-89229] - Staining of human IFITM1 in human colon carcinoma with rabbit monoclonal antibody (1:200.)")
![Immunohistochemistry-Paraffin: IFITM1 Antibody (001) [NBP2-89229] - Staining of human IFITM1 in human tonsil with rabbit monoclonal antibody (1:200).](http://images.novusbio.com/fullsize/IFITM1-Antibody-001-Immunohistochemistry-Paraffin-NBP2-89229-img0001.jpg)
![Western Blot: LST1 Antibody (LST1/02) [NBP1-45072] - Analysis (non-reducing conditions) of LST1 in whole cell lysate of U937 human Caucasian histiocytic lymphoma cell line. Lane 1: immunostaining with Isotype mouse IgG1 control (PPV-06) Lane 2-3: immunostaining with anti-human LST1 (LST1/02), two independent batches. Note: It migrates on SDS PAGE gels as approximately 25-28 kDa molecule.](http://images.novusbio.com/fullsize/LST1-Antibody-LST1-02-Western-Blot-NBP1-45072-img0002.jpg "Western Blot: LST1 Antibody (LST1/02) [NBP1-45072] - Analysis (non-reducing conditions) of LST1 in whole cell lysate of U937 human Caucasian histiocytic lymphoma cell line. Lane 1: immunostaining with Isotype mouse IgG1 control (PPV-06) Lane 2-3: immunostaining with anti-human LST1 (LST1/02), two independent batches. Note: It migrates on SDS PAGE gels as approximately 25-28 kDa molecule.")
![Flow Cytometry: CD30/TNFRSF8 Antibody (Ber-H8) [NBP3-09139] - Analysis (surface staining) of K562 cells with anti-human CD30 (Ber-H8) purified, GAM APC.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-Ber-H8-Flow-Cytometry-NBP3-09139-img0001.jpg "Flow Cytometry: CD30/TNFRSF8 Antibody (Ber-H8) [NBP3-09139] - Analysis (surface staining) of K562 cells with anti-human CD30 (Ber-H8) purified, GAM APC.")
![Western Blot: MDA5 Antibody (PSH03-56) [NBP3-32581] - Western blot analysis of MDA5 on different lysates with Rabbit anti-MDA5 antibody (NBP3-32581) at 1/2,000 dilution. Lane 1: THP-1 cell lysate (20 ug/Lane) Lane 2: HepG2 cell lysate (20 ug/Lane) Lane 3: Jurkat cell lysate (20 ug/Lane) Lane 4: Daudi cell lysate (20 ug/Lane) Lane 5: Raji cell lysate (20 ug/Lane) Lane 6: MCF7 cell lysate (20 ug/Lane) Lane 7: HeLa cell lysate (20 ug/Lane) Lane 8: SH-SY5Y cell lysate (20 ug/Lane) Lane 9: A549 cell lysate (20 ug/Lane) Lane 10: A431 cell lysate (20 ug/Lane) Lane 11: Mouse pancreas tissue lysate (40 ug/Lane) Lane 12: Rat kidney tissue lysate (40 ug/Lane) Lysates/proteins at 10 ug/Lane. Predicted band size: 117 kDa Observed band size: 140/100 kDa Exposure time: 3 minutes; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32581) at 1/2,000 dilution was used in 5% NFDM/TBST at 4 overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1/50,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-32581_rabbit-mda5-mab-psh03-56-278202415295575.jpg "Western Blot: MDA5 Antibody (PSH03-56) [NBP3-32581] - Western blot analysis of MDA5 on different lysates with Rabbit anti-MDA5 antibody (NBP3-32581) at 1/2,000 dilution. Lane 1: THP-1 cell lysate (20 ug/Lane) Lane 2: HepG2 cell lysate (20 ug/Lane) Lane 3: Jurkat cell lysate (20 ug/Lane) Lane 4: Daudi cell lysate (20 ug/Lane) Lane 5: Raji cell lysate (20 ug/Lane) Lane 6: MCF7 cell lysate (20 ug/Lane) Lane 7: HeLa cell lysate (20 ug/Lane) Lane 8: SH-SY5Y cell lysate (20 ug/Lane) Lane 9: A549 cell lysate (20 ug/Lane) Lane 10: A431 cell lysate (20 ug/Lane) Lane 11: Mouse pancreas tissue lysate (40 ug/Lane) Lane 12: Rat kidney tissue lysate (40 ug/Lane) Lysates/proteins at 10 ug/Lane. Predicted band size: 117 kDa Observed band size: 140/100 kDa Exposure time: 3 minutes; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32581) at 1/2,000 dilution was used in 5% NFDM/TBST at 4 overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1/50,000 dilution was used for 1 hour at room temperature.")
![Western Blot: Zeta Opioid Receptor Antibody [NBP2-99484] - Anti-Zeta Opioid Receptor rabbit polyclonal antibody at 1:500 dilution. Lane A: HepG2 Whole Cell Lysate Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 73 kDa](http://images.novusbio.com/fullsize/Zeta-Opioid-Receptor-Antibody-Western-Blot-NBP2-99484-img0003.jpg "Western Blot: Zeta Opioid Receptor Antibody [NBP2-99484] - Anti-Zeta Opioid Receptor rabbit polyclonal antibody at 1:500 dilution. Lane A: HepG2 Whole Cell Lysate Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 73 kDa")
![Immunoprecipitation: Zeta Opioid Receptor Antibody [NBP2-99484] - Zeta Opioid Receptor was immunoprecipitated using: Lane A: 0.5 mg HepG2 Whole Cell Lysate 4 ul anti-Zeta Opioid Receptor rabbit polyclonal antibody and 60 ug of Immunomagnetic beads Protein A/G. Primary antibody: Anti-Zeta Opioid Receptor rabbit polyclonal antibody, at 1:100 dilution. Secondary antibody: Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 73 kDa. Observed band size: 90 kDa](http://images.novusbio.com/fullsize/Zeta-Opioid-Receptor-Antibody-Immunoprecipitation-NBP2-99484-img0004.jpg)
![Western Blot: S100A11 Antibody [NBP2-99718] - Anti-S100A11 rabbit polyclonal antibody at 1:500 dilution. Lane A: Hela Whole Cell Lysate. Lane B: SKBR3 Whole Cell Lysate. Lane C: PC-3 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 11 kDa. Observed band size: 11 kDa](http://images.novusbio.com/fullsize/S100A11-Antibody-Western-Blot-NBP2-99718-img0004.jpg "Western Blot: S100A11 Antibody [NBP2-99718] - Anti-S100A11 rabbit polyclonal antibody at 1:500 dilution. Lane A: Hela Whole Cell Lysate. Lane B: SKBR3 Whole Cell Lysate. Lane C: PC-3 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 11 kDa. Observed band size: 11 kDa")
![Immunoprecipitation: S100A11 Antibody [NBP2-99718] - S100A11 was immunoprecipitated using: Lane A: 0.5 mg Hela Whole Cell Lysate. 2 ul anti-S100A11 rabbit polyclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-S100A11 rabbit polyclonal antibody, at 1:200 dilution. Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 11 kDa. Observed band size: 11 kDa](http://images.novusbio.com/fullsize/S100A11-Antibody-Immunoprecipitation-NBP2-99718-img0003.jpg)
![SDS-Page: Human IL-3 Protein [NBP2-34863]](http://images.novusbio.com/fullsize/Human-IL-3-Protein-SDS-Page-NBP2-34863-img0001.jpg "SDS-Page: Human IL-3 Protein [NBP2-34863]")